Interferon-alpha-2b in the management of patients with relapsed and/or refractory Hodgkin's disease.
Maloisel
F
F
Voillat
L
L
Chenard
M P
MP
Boehn
A
A
Lioure
B
B
Oberling
F
F
D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D011994:Recombinant Proteins; D012008:Recurrence
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins